David Messika–Zeitoun

Papers

Total Citations

H-Index

About

David Messika–Zeitoun is a leading authority in the field of valvular heart disease, with a specific focus on degenerative mitral regurgitation (MR). His research has fundamentally advanced the understanding and management of primary MR, the most common cause of organic mitral valve disease in developed countries. A cornerstone of his work involves establishing the gold standard role of surgical mitral valve repair, demonstrating that it is associated with excellent long-term outcomes, including superior survival and freedom from reoperation. Through his longitudinal studies, such as his 2023 work on outcomes following surgical repair, Messika–Zeitoun has provided critical data that guide clinical decision-making for patients with severe MR. His contributions extend to advocating for improved care pathways, as highlighted in his 2020 publication, aiming to optimize patient selection and timing of intervention. With a career dedicated to refining the natural history and treatment of mitral valve disease, Messika–Zeitoun’s research has shaped contemporary surgical and interventional strategies, making him a pivotal figure in cardiovascular medicine whose work directly impacts patient prognosis and quality of life.